AusperBio Therapeutics clinical trials
AusperBio Therapeutics is the lead sponsor of 3 current clinical trials in our UK, USA, France, Spain, Italy, Canada, China, Japan, South Korea, Taiwan, Singapore, Australia and EU (CTIS) registers. 2 are recruiting patients now. All registered phases are Phase 2. The drugs named most often in its trials are AHB-137. The most-studied condition is Hepatitis B, Chronic.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by AusperBio Therapeutics
2 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
NCT07370207 · ClinicalTrials.gov ↗ · Hepatitis B, Chronic
Drug: AHB-137 |
Phase 2 | Recruiting | 2026-03 | China, Japan, South Korea, Taiwan, Singapore, Australia |
|
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
NCT07654283 · Hepatitis B, Chronic
Drug: AHB-137 |
Phase 2 | Recruiting | 2026-09 | UK, USA, France, Spain, Italy, Canada |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
AusperBio Therapeutics in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System with AusperBio Therapeutics as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
Aspire-202: A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B in the North America and Europe Regions
2025-524159-30-00 · CTIS ↗ · Virus Diseases
Drug: AHB-137 |
Phase 2 | Authorised | Italy |
Drugs in AusperBio Therapeutics trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in AusperBio Therapeutics trials
1 conditionBy trial register
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Hepatitis B, Chronic
| Sponsor | Trials |
|---|---|
| Third Affiliated Hospital, Sun Yat-Sen University | 3 |
| Huashan Hospital | 3 |
Sponsors with the most current trials registered for this condition.
Questions about AusperBio Therapeutics trials
How many clinical trials does AusperBio Therapeutics sponsor?
AusperBio Therapeutics is the lead sponsor of 2 current trials on ClinicalTrials.gov in our UK, USA, France, Spain, Italy, Canada, China, Japan, South Korea, Taiwan, Singapore and Australia registers, and 1 authorised or ongoing trial in the EU register (CTIS), as of the registry sync on 23 October 2026. Completed and withdrawn studies are not counted.
Are AusperBio Therapeutics trials recruiting?
Yes. 2 of its 2 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is AusperBio Therapeutics testing?
Its current trials name 1 drug or biological as interventions. The most frequent are AHB-137 (3). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 23 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.